| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―04 |
A 5-year perspective on coronavirus diseases 2019 (COVID-19) |
David S. C. Hui, Alimuddin Zumla |
| 2 |
[GO] |
2024―Jan―31 |
Increased exacerbations of bronchiectasis following recovery from mild COVID-19 in patients with non-cystic fibrosis bronchiectasis |
Wang Chun Kwok, James Chung Man Ho, Terence Chi Chun Tam, Mary Sau Man Ip, David Chi Leung Lam |
| 3 |
[GO] |
2023―Sep―21 |
Continuous positive airway pressure or high-flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure unrelated to COVID-19: Another brick in the wall? |
Rémi Coudroy |
| 4 |
[GO] |
2023―Sep―16 |
Treatable traits for long COVID |
Hayley Lewthwaite, Anthony Byrne, Bruce Brew, Peter G. Gibson |
| 5 |
[GO] |
2023―Sep―08 |
Long-term effects of extreme smoke exposure on COVID-19: A cohort study |
Tyler J. Lane, Matthew Carroll, Brigitte M. Borg, Tracy A. McCaffrey, Catherine L. Smith, Caroline X. Gao, et al. (+5) David Brown, David Poland, Shantelle Allgood, Jillian Ikin, Michael J. Abramson |
| 6 |
[GO] |
2023―Aug―22 |
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia |
Giacomo Sgalla, Paolo Maria Leone, Gina Gualano, Jacopo Simonetti, Alessia Comes, Diana Verdirosi, et al. (+8) Francesco Di Gennaro, Anna Rita Larici, Stefania Ianniello, Giuseppe Cicchetti, Nicoletta Fusco, Marcello Pani, Fabrizio Palmieri, Luca Richeldi |
| 7 |
[GO] |
2023―Jul―27 |
Letter from the United States: An update on the New York experience with COVID-19 |
Edward J. Schenck, Meredith L. Turetz, Michael S. Niederman |
| 8 |
[GO] |
2023―Jul―21 |
A snorkel mask with a 3D-printed adaptor to HEPA filter was used in a COVID-19 emergency ward to provide safe respiratory support |
Camila Vitelli Molinari, Vivian Bertoni Xavier, Ronaldo Fernandes Rosa, Maria Augusta Junqueira Alves, Luiz Antônio Rivetti, Vera Lúcia dos Santos Alves |
| 9 |
[GO] |
2023―May―19 |
Let us start thinking about what to do in the event of a global influenza pandemic |
Richard Beasley |
| 10 |
[GO] |
2023―May―08 |
Covid-19 pandemic and asthma: What did we learn? |
Chloe I. Bloom |
| 11 |
[GO] |
2022―Nov―02 |
Are we coming out from the
COVID
-19 pandemic? |
Chi Chiu Leung, Andrew C. K. Lee |
| 12 |
[GO] |
2022―Oct―17 |
Two years of the pandemic suppressed deaths from
non-COVID
-19 respiratory infections: A nationwide surveillance in Japan |
Nobuyuki Horita, Takeshi Fukumoto |
| 13 |
[GO] |
2022―Sep―22 |
The ill winds of
COVID
-19: How the pandemic improved respiratory health for some |
Robert J. Hancox, Catherina L. Chang |
| 14 |
[GO] |
2022―Aug―11 |
Respiratory admissions before and during the COVID-19 pandemic with mediation analysis of air pollutants, mask-wearing and influenza rates |
Fanny Wai San Ko, Louis Ho Shing Lau, So Shan Ng, Terry Cheuk Fung Yip, Grace Lai Hung Wong, Ka Pang Chan, et al. (+2) Tat On Chan, David Shu Cheong Hui |
| 15 |
[GO] |
2022―Aug―10 |
Pulmonary function testing during
SARS-CoV
-2: An
ANZSRS
/
TSANZ
position statement |
Brigitte M. Borg, Christian Osadnik, Keith Adam, David G. Chapman, Catherine E. Farrow, Vanda Glavas, et al. (+6) Kerry Hancock, Celia J. Lanteri, Ewan G. Morris, Nicholas Romeo, Elena K. Schneider-Futschik, Hiran Selvadurai |
| 16 |
[GO] |
2022―May―05 |
Innovations during the
Covid
-19 pandemic to maintain delivery of care for vocal cord dysfunction (
VCD
) in a multidisciplinary team (
MDT
) clinic |
Joo Koh, Malcolm Baxter, Debra Phyland, Laurence Ruane, Adriana Avram, Elizabeth Leahy, et al. (+4) Kenneth Lau, Martin MacDonald, Paul Leong, Philip Bardin |
| 17 |
[GO] |
2022―Apr―27 |
Reply: Hearing the voices of Australian frontline healthcare workers during the COVID-19 pandemic |
Natasha Smallwood, Jaimie-Lee Maple, Karen Willis |
| 18 |
[GO] |
2022―Apr―13 |
The ongoing impact of
COVID
-19 pandemic restrictions on the cardio-respiratory health of New Zealanders |
Sarah M. Fairweather, Catherina L. Chang, Robert J. Hancox |
| 19 |
[GO] |
2022―Mar―25 |
Lessons learned from staging the Olympics during a pandemic |
Yoichi Nakanishi |
| 20 |
[GO] |
2022―Jan―20 |
COVID
-19 infection and the broader impacts of the pandemic on healthcare workers |
Natasha Smallwood, Warren Harrex, Megan Rees, Karen Willis, Catherine M. Bennett |
| 21 |
[GO] |
2022―Jan―05 |
Changes to clinical education during the
COVID
-19 pandemic: Challenges and opportunities |
Mark Lavercombe |
| 22 |
[GO] |
2021―Dec―06 |
COVID-19
and critical care capacity: Can we mitigate demand? |
Matthew Byrne, Timothy E. Scott, Jonathan Sinclair, Nachiappan Chockalingam |
| 23 |
[GO] |
2021―Nov―22 |
Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic |
Nobuyuki Horita, Hideaki Kato, Keisuke Watanabe, Yu Hara, Nobuaki Kobayashi, Takeshi Kaneko |
| 24 |
[GO] |
2021―Nov―20 |
P5-72: Lipid involvements on inflammatory changes and clinical outcomes in patients with COVID-19 |
|
| 25 |
[GO] |
2021―Nov―20 |
P5-89: Effectiveness of a questionnaire to screen COVID-19 |
|
| 26 |
[GO] |
2021―Nov―20 |
P5-90: Association of persistent and delayed symptoms with pneumonia in COVID-19 |
|
| 27 |
[GO] |
2021―Nov―20 |
P5-91: Clinical characteristics and mortality risk in patients with severe COVID-19 |
|
| 28 |
[GO] |
2021―Nov―20 |
P5-23: Neurological complications of patients with COVID-19 |
|
| 29 |
[GO] |
2021―Nov―20 |
P5-53: Early initiation of steroid therapy is a risk factor of treatment failure in patients with COVID-19 |
|
| 30 |
[GO] |
2021―Nov―20 |
P5-58: Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID-19 |
|
| 31 |
[GO] |
2021―Nov―20 |
P5-47: Safety and efficacy of remdesivir, baricitinib and high-dose steroid combination therapy in patients hospitalized with COVID-19 |
|
| 32 |
[GO] |
2021―Nov―20 |
P1-26: Cytokines secreted by PC9-MET and PC9 cells may worsen COVID-19 |
|
| 33 |
[GO] |
2021―Nov―20 |
P5-34: Long-haul COVID-19 among University of Santo Tomas hospital-health care workers following hospitalization for COVID-19 pneumonia |
|
| 34 |
[GO] |
2021―Nov―20 |
P6-56: One case of a patient on maintenance dialysis who concurrently suffered from both COVID-19 and a relapse of pulmonary tuberculosis |
|
| 35 |
[GO] |
2021―Nov―20 |
P6-58: Pneumothorax as a clinical manifestation of lung tuberculosis with co-infection COVID-19 and bacterial pneumonia |
|
| 36 |
[GO] |
2021―Nov―20 |
P1-86: Prone positioning treatment for COVID-19 ARDS patients with pneumomediastinum and subcutaneous emphysema during treatment of mechanical ventilation.: A two cases report |
|
| 37 |
[GO] |
2021―Nov―20 |
P11-6: Indices of endogenous intoxication in patients with COVID-19 associated pneumonia |
|
| 38 |
[GO] |
2021―Nov―20 |
P5-81: Correlation of serum ferritin level with disease severity of COVID-19 at Arifin Achmad General Hospital Riau Province |
|
| 39 |
[GO] |
2021―Nov―20 |
P5-82: The correlation of cycle threshold value with severity of COVID-19 at the isolation of new emerging and re-emerging infectious diseases room Arifin Achmad General Hospital Riau Province Indonesia |
|
| 40 |
[GO] |
2021―Nov―20 |
P1-78: Descriptive analysis of patients attending an outpatient post COVID-19 clinic in a tertiary care hospital in Sri Lanka |
|
| 41 |
[GO] |
2021―Nov―20 |
P5-8: Risk factors for mortality of COVID-19 confirmed cases admitted at lung center of the Philippines |
|
| 42 |
[GO] |
2021―Nov―20 |
P5-113: Baseline characteristics, clinical course and outcomes of COVID-19 confirmed healthcare workers in the University of Santo Tomas Hospital |
|
| 43 |
[GO] |
2021―Nov―20 |
P11-5: Clinical outcomes of hypoxemic, COVID-19 confirmed patients on high-flow nasal cannula (HFNC) therapy in a tertiary government hospital in Metro Manila, Philippines: A retrospective study |
|
| 44 |
[GO] |
2021―Nov―20 |
O19-3: The outcomes of evolving treatment regimens among COVID-19 Confirmed severe and critical cases admitted at the lung center of the Philippines |
|
| 45 |
[GO] |
2021―Nov―20 |
P5-98: Vitamin D deficiency as a marker of severe COVID-19 course |
|
| 46 |
[GO] |
2021―Nov―20 |
P5-104: Reinfection of COVID-19 critical condition in miliary tuberculosis case with multiple comorbidities |
|
| 47 |
[GO] |
2021―Nov―20 |
P6-44: Case report of a newly diagnosed bacteriologically confirmed pulmonary tuberculosis in a patient with COVID-19 critical infection |
|
| 48 |
[GO] |
2021―Nov―20 |
P5-54: Guillain-Barre syndrome-acute motor axonal neuropathy as neurologic sequela in a COVID-19 critically-ill patient: A case report |
|
| 49 |
[GO] |
2021―Nov―20 |
P5-77: Prognostic factors associated with death and progressiveness of COVID-19 disease at Sanglah Hospital, Denpasar |
|
| 50 |
[GO] |
2021―Nov―20 |
P5-30: Risk factors for hospitalization in patients with mild SARS-CoV-2 infection (COVID-19) during residential or home care |
|
| 51 |
[GO] |
2021―Nov―20 |
P5-42: Assessment of outcome and risk categorization of COVID-19 exposed healthcare workers using a risk assessment tool in a Tertiary Care Hospital, Sri Lanka |
|
| 52 |
[GO] |
2021―Nov―20 |
P5-88: Study of C reactive protein (HS-CRP) in post COVID-19 geriatric patients |
|
| 53 |
[GO] |
2021―Nov―20 |
P5-101: A case report of COVID-19 in an adult filipino with HIV-associated histoplasmosis |
|
| 54 |
[GO] |
2021―Nov―20 |
P13-2: The effect of vitamin D on the course of COVID-19 in children |
|
| 55 |
[GO] |
2021―Nov―20 |
P5-6: A convenient risk prediction score for COVID-19 in determining whether hospitalization should be recommended: Kanagawa admission priority assessment score (KAPAS) |
|
| 56 |
[GO] |
2021―Nov―20 |
P5-132: Rehabilitation interventions and tasks for patients with COVID-19 in our hospital |
|
| 57 |
[GO] |
2021―Nov―20 |
P5-60: Clinical and radiological features of COVID-19 in pregnant women: A case-control study |
|
| 58 |
[GO] |
2021―Nov―20 |
P1-74: COVID-19 in renal transplant recipients in a resource poor setting: A case series |
|
| 59 |
[GO] |
2021―Nov―20 |
P1-95: It runs in the family: case series of severe and critical COVID-19 in three family members |
|
| 60 |
[GO] |
2021―Nov―20 |
P5-74: Serial changes in clinical characteristics of COVID-19 infected patients |
|
| 61 |
[GO] |
2021―Nov―20 |
P16-97: Secondary organizing pneumonia following COVID-19 infection |
|
| 62 |
[GO] |
2021―Nov―20 |
P5-118: Clinical outcomes of diffuse alveolar damage and organising pneumonia in severe COVID-19 infection |
|
| 63 |
[GO] |
2021―Nov―20 |
O5-2: Factors affecting compliance to COVID-19 infection prevention and control measures and its effects on the risk of COVID-19 infection among physicians in a tertiary government hospital |
|
| 64 |
[GO] |
2021―Nov―20 |
P5-138: Correlation between brixia score and RTPCR-SARS-CoV-2 result of pediatric patients with suspected or confirmed COVID-19 infection seen at Chong Hua Hospital, Cebu City from March 2020 to February 2021 |
|
| 65 |
[GO] |
2021―Nov―20 |
P1-79: Diaphragm dysfunction developed after COVID-19 infection without pneumonia |
|
| 66 |
[GO] |
2021―Nov―20 |
P1-24: Correlation of chest CT findings and severity of coronavirus disease (COVID-19) infections in patients admitted at Chinese General Hospital and Medical Center |
|
| 67 |
[GO] |
2021―Nov―20 |
P5-13: COVID-19 mobile test unit (COMBAT): A novel pharyngeal sampling platform for COVID-19 testing in Malaysia |
|
| 68 |
[GO] |
2021―Nov―20 |
P1-15: Chest X-ray improvement in COVID-19 moderate symptoms with remdesvir and favipiravir: A comparative study |
|
| 69 |
[GO] |
2021―Nov―20 |
P5-37: Community-acquired respiratory virus cases mimic COVID-19 on lung computed tomography |
|
| 70 |
[GO] |
2021―Nov―20 |
P6-5: Impact of COVID-19 on tuberculosis in Japan; A national database analysis |
|
| 71 |
[GO] |
2021―Nov―20 |
P16-60: Post COVID-19 organizing pneumonia treated with mycophenolate mofetil |
|
| 72 |
[GO] |
2021―Nov―20 |
P1-51: Status of palliative care in respiratory disease before and after COVID-19 outbreak |
|
| 73 |
[GO] |
2021―Nov―20 |
P3-6: A clinical analysis of PAP (pulmonary alveolar proteinosis) s diagnosed with difficulty in the COVID-19 pandemic |
|
| 74 |
[GO] |
2021―Nov―20 |
P12-8: New style for bronchoscopy to prevent infection under COVID-19 pandemic |
|
| 75 |
[GO] |
2021―Nov―20 |
P8-180: Growth inhibitory effects of chemotherapeutics drugs in EGFR-mutated PC9 cells during the COVID-19 pandemic |
|
| 76 |
[GO] |
2021―Nov―20 |
P1-8: Impact on inhalation adherence of asthma and COPD patients during the COVID-19 pandemic |
|
| 77 |
[GO] |
2021―Nov―20 |
P16-95: High incidence of MPO-ANCA positive interstitial pneumonia during the COVID-19 pandemic |
|
| 78 |
[GO] |
2021―Nov―20 |
O17-1: Asthma status during COVID-19 pandemic |
|
| 79 |
[GO] |
2021―Nov―20 |
P4-10: Burnout among healthcare workers during COVID-19 pandemic in Aceh, Indonesia |
|
| 80 |
[GO] |
2021―Nov―20 |
P5-92: Respiratory viruses during COVID-19 pandemic in Okinawa, Japan |
|
| 81 |
[GO] |
2021―Nov―20 |
P5-33: Impacts of the COVID-19 pandemic on hospitalizations for pneumonia in Brazil |
|
| 82 |
[GO] |
2021―Nov―20 |
P4-25: The dynamics of the quality of life of healthy people amid the COVID-19 pandemic when soy and pumpkin products are included in the diet |
|
| 83 |
[GO] |
2021―Nov―20 |
P5-109: A fatal case of multiple mycotic pulmonary artery aneurysms due to
Aspergillus terreus
in a post COVID-19 patient |
|
| 84 |
[GO] |
2021―Nov―20 |
P1-2: Correlations in physical symptoms, blood biochemical findings, and chest ct images in an early phase of COVID-19 patient |
|
| 85 |
[GO] |
2021―Nov―20 |
P11-11: Bilateral iliopsoas hematomas in a severe COVID-19 patient treated with unfractionated heparin: A case report and review of literature |
|
| 86 |
[GO] |
2021―Nov―20 |
P12-12: Bronchoscopy with n-acetylcysteine lavage in a COVID-19 patient with massive grade IV inhalation injury |
|
| 87 |
[GO] |
2021―Nov―20 |
P5-46: Myocardial injury association with severity of disease in hospitalized COVID-19 patients |
|
| 88 |
[GO] |
2021―Nov―20 |
P5-108: The association between awake prone positioning and mortality in COVID-19 patients |
|
| 89 |
[GO] |
2021―Nov―20 |
P1-13: Effect of bromhexine among COVID-19 patients - A meta-analysis |
|
| 90 |
[GO] |
2021―Nov―20 |
P5-20: The prevalence of comorbid respiratory disease among COVID-19 patients, and mortality during the first wave in Japan: A nationwide survey by the Japanese Respiratory Society |
|
| 91 |
[GO] |
2021―Nov―20 |
P5-127: Clinical characteristics of SARS-CoV-2 infected (COVID-19) patients and mutant viral strains in rural area of Japan |
|
| 92 |
[GO] |
2021―Nov―20 |
P5-27: Evaluation of serum interferon lambda 3 in hospitalized COVID-19 patients as a biomarker to predict the severity |
|
| 93 |
[GO] |
2021―Nov―20 |
P5-83: The correlation between cycle threshold polymerase chain reaction COVID-19 with the extent of chest X-ray abnormalities and D-dimer in COVID-19 patients at Arifin Achmad General Hospital Riau Province |
|
| 94 |
[GO] |
2021―Nov―20 |
P5-135: D-dimer as a predictor severity and mortality in hospitalized COVID-19 patients at Saiful Anwar General Hospital Malang |
|
| 95 |
[GO] |
2021―Nov―20 |
P1-9: Predictive factor of high-flow nasal oxygen failure in COVID-19 patients at tertiary hospital in Jakarta |
|
| 96 |
[GO] |
2021―Nov―20 |
P5-136: The correlation between leucocyte, lymphocyte, thrombocyte, and sofa score on the severity of COVID-19 patients hospitalized in the PINERE Ward of Saiful Anwar Hospital |
|
| 97 |
[GO] |
2021―Nov―20 |
O6-4: Treatment outcomes of COVID-19 patients in Hong Kong's first designated infection control centre and the impact of emergent SARS-CoV-2 mutant strains from imported cases |
|
| 98 |
[GO] |
2021―Nov―20 |
P1-36: Multicenter study elucidating factors associated with sequelae of discharged COVID-19 patients in Japan |
|
| 99 |
[GO] |
2021―Nov―20 |
P5-68: The use of an institutionalized respiratory protocol as a decision-making tool improved outcomes among severe and critically-ill COVID-19 patients in Perpetual Succour Hospital |
|
| 100 |
[GO] |
2021―Nov―20 |
O8-5: Prevalence of acute myocardial injury among COVID-19 patients in Persahabatan Hospital, Jakarta |
|
| 101 |
[GO] |
2021―Nov―20 |
P5-145: COVID-19: Performance of oseltamivir and isoprinosine in neutrophil-to-lymphocyte ratio improvement from confirmed COVID-19 patients in Saiful Anwar General Hospital, Malang |
|
| 102 |
[GO] |
2021―Nov―20 |
P5-36: Association of C-reactive protein (CRP), serum ferritin, and patient outcome in COVID-19 patients in tertiary referral hospital |
|
| 103 |
[GO] |
2021―Nov―20 |
P5-105: Relationship of total thrombocyte, lymphocyte account and PLR (platelet lymphocyte ratio) to severity degree of COVID-19 patients in ward |
|
| 104 |
[GO] |
2021―Nov―20 |
P11-14: Blood gas analysis and alveolar-arterial gradient as predictor of mortality confirmed COVID-19 patients outcome in Tertiary Referral Hospital |
|
| 105 |
[GO] |
2021―Nov―20 |
P5-112: The relationship of chest X-ray in COVID-19 patients towards disease severity at Arifin Achmad Regional General Hospital, Riau Province |
|
| 106 |
[GO] |
2021―Nov―20 |
P5-76: Prolonged viral clearance in COVID-19 patients treated with tocilizumab |
|
| 107 |
[GO] |
2021―Nov―20 |
P5-142: A case series on corticosteroid use in COVID-19 patients who suffered from chronic lung disease |
|
| 108 |
[GO] |
2021―Nov―20 |
P5-150: COVID-19 patients with a late diagnosis of HIV |
|
| 109 |
[GO] |
2021―Nov―20 |
P5-70: Effectiveness of favipiravir in COVID-19 patients with multiple (≥2) or less (<2) comorbidities: A real word experience from India |
|
| 110 |
[GO] |
2021―Nov―20 |
P5-106: Japanese, multicenter, phase II trial of combination therapy with favipiravir and methylprednisolone for COVID-19 patients with non-critical respiratory failure: the J-critical trial |
|
| 111 |
[GO] |
2021―Nov―20 |
P5-79: Clinical comparison of the first wave and the later waves in COVID-19 patients with pneumonia |
|
| 112 |
[GO] |
2021―Nov―20 |
P5-64: Therapeutic effectiveness & safety of favipiravir in COVID-19 patients with risk factors for mortality: Clinical practice experience from India |
|
| 113 |
[GO] |
2021―Nov―20 |
P5-19: Spontaneous pneumothorax in Indonesian COVID-19 patients: A retrospective case series |
|
| 114 |
[GO] |
2021―Nov―20 |
P5-71: Rapidly progressive honeycombing in a spontaneously breathing patient with COVID-19 pneumonia |
|
| 115 |
[GO] |
2021―Nov―20 |
P5-62: Evaluation of lung cell populations in severe COVID-19 pneumonia |
|
| 116 |
[GO] |
2021―Nov―20 |
P5-87: Time course of oxygen demand in patients with COVID-19 pneumonia |
|
| 117 |
[GO] |
2021―Nov―20 |
P5-85: Staged treatment of middle lobe lung gangrene using the vacuum-assisted closure therapy in a patient with severe COVID-19 pneumonia |
|
| 118 |
[GO] |
2021―Nov―20 |
P5-152: Familial ciclesonide-responsive cases of COVID-19 pneumonia |
|
| 119 |
[GO] |
2021―Nov―20 |
P5-144: Infected pneumatoceles complicating the course of COVID-19 pneumonia |
|
| 120 |
[GO] |
2021―Nov―20 |
P1-77: Long-COVID syndrome associated with COVID-19 pneumonia |
|
| 121 |
[GO] |
2021―Nov―20 |
P5-57: Comparison of chest HRCT findings between COVID-19 pneumonia and anti-MDA5 antibody-positive interstitial pneumonia by computer-based quantitative CT image analysis |
|
| 122 |
[GO] |
2021―Nov―20 |
P5-14: An age-matched comparison between COVID-19 pneumonia and pneumococcal pneumonia cases |
|
| 123 |
[GO] |
2021―Nov―20 |
P5-15: A case of recurred exacerbations and remissions of COVID-19 pneumonia in a patient with b-cell lymphoma undergoing chemotherapy |
|
| 124 |
[GO] |
2021―Nov―20 |
P5-43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID-19 pneumonia in pregnancy |
|
| 125 |
[GO] |
2021―Nov―20 |
P5-26: Validity of PIRO-score as an assessment tool for mortality risk of COVID-19 pneumonia in World Citi Medical Center. A retrospective observational cohort study |
|
| 126 |
[GO] |
2021―Nov―20 |
P11-13: Diffuse pulmonary hemorrhage, a catastrophic outcome of a 57-year-old venezuelan, with COVID-19 pneumonia, who developed multiple thrombosis and aman-variant GBS |
|
| 127 |
[GO] |
2021―Nov―20 |
P1-83: A case report of primi 30 weeks of pregnancy with COVID-19 pneumonia with dengue fever |
|
| 128 |
[GO] |
2021―Nov―20 |
P5-97: High-dose methylprednisolone in combination with tocilizumab in hospitalized patients with critical COVID-19 pneumonia: A case series |
|
| 129 |
[GO] |
2021―Nov―20 |
P5-67: Predictors of mortality in severe COVID-19 pneumonia: An interim analysis from a single Tertiary Care Centre in Central Sri Lanka |
|
| 130 |
[GO] |
2021―Nov―20 |
P5-80: A case report of pneumothorax associated with COVID-19 pneumoniae |
|
| 131 |
[GO] |
2021―Nov―20 |
P5-143: Post-corona virus disease 2019 (COVID-19) pneumothorax |
|
| 132 |
[GO] |
2021―Nov―20 |
P15-16: Modified dose thrombolysis in a COVID-19 related massive acute pulmonary embolism: A case report |
|
| 133 |
[GO] |
2021―Nov―20 |
P5-125: Abrupt cessation of systemic corticosteroid in coronavirus disease 19 (COVID-19) related secondary organizing pneumonia resulted in a rebound |
|
| 134 |
[GO] |
2021―Nov―20 |
O10-1: Community-led tuberculosis and COVID-19 risk communication in the Vietnamese migrant population in Japan |
|
| 135 |
[GO] |
2021―Nov―20 |
P5-28: Correlation of serum interleukin-6 level and COVID-19 severity on hospital admission and survival |
|
| 136 |
[GO] |
2021―Nov―20 |
P14-9: Lung function analysis of COVID-19 survivors in dr. Zainoel Abidin Hospital Banda Aceh, Indonesia |
|
| 137 |
[GO] |
2021―Nov―20 |
P5-122: A case of secondary organizing pneumonia caused by relapse of inflammation after COVID-19 treatment with systemic corticosteroid and tocilizumab |
|
| 138 |
[GO] |
2021―Nov―20 |
O8-4: Determination of antibody titers of filipino healthcare workers after COVID-19 vaccination (Sinovac and Astrazenica) - A preliminary report |
|
| 139 |
[GO] |
2021―Nov―20 |
O7-1: Structural differentiation of the spike glycoprotein from SARS-CoV-2 COVID-19 variants of concern compared to other human-infecting coronaviruses: A computational study with clinical implications |
|
| 140 |
[GO] |
2021―Nov―20 |
P11-2: Clinical profiles and respiratory system mechanics of mechanically ventilated patients with COVID-19 versus non-COVID-19-associated ARDS |
|
| 141 |
[GO] |
2021―Nov―20 |
P5-31: High prevalence of silent hypoxia among patients with COVID-19 warrants screening for oxyhemoglobin desaturation among patients with fever, cough or dyspnea |
|
| 142 |
[GO] |
2021―Nov―20 |
P5-40: An autopsy case of COVID-19 with disseminated mucormycosis |
|
| 143 |
[GO] |
2021―Nov―20 |
P7-61: Management & caring for patients of COPD with COVID-19: A current perspective |
|
| 144 |
[GO] |
2021―Nov―20 |
P5-121: Inhaled beclomethasone in the treatment of early COVID-19: A placebo-controlled, randomized trial |
|
| 145 |
[GO] |
2021―Nov―20 |
O8-3: The effectiveness of the combined use of remdesivir and regdanvimab (CT-P59) in patients with severe COVID-19: A single center retrospective study |
|
| 146 |
[GO] |
2021―Nov―20 |
P11-7: Issues related to ECMO management in critically ill patients with COVID-19: A systematic review and meta-analysis |
|
| 147 |
[GO] |
2021―Nov―20 |
P5-111: SARS-CoV-2 PCR and antigen positivity continued for 3 months after treatment for severe COVID-19: Case report |
|
| 148 |
[GO] |
2021―Nov―20 |
P5-51: Organizing pneumonia post COVID-19: Outcomes of treatment with corticosteroids in the outpatient setting |
|
| 149 |
[GO] |
2021―Nov―20 |
P5-93: Therapeutic effectiveness and tolerability of favipiravir in mild COVID-19: Real world experience from India |
|
| 150 |
[GO] |
2021―Nov―20 |
P5-32: Investigation of exacerbation factors in patients with coronavirus disease 2019 |
|
| 151 |
[GO] |
2021―Nov―20 |
P6-50: Primary multidrug-resistant tuberculosis in coronavirus disease 2019 |
|
| 152 |
[GO] |
2021―Nov―20 |
P5-94: The usefulness of a combination of age, body mass index, and blood urea nitrogen as prognostic factors in predicting oxygen requirements in patients with coronavirus disease 2019 |
|
| 153 |
[GO] |
2021―Nov―20 |
P5-56: Predictive model for the development of critical coronavirus disease 2019 in Japan |
|
| 154 |
[GO] |
2021―Nov―20 |
P8-37: Delayed visit and treatment of lung cancer during the coronavirus disease 2019 pandemic in Japan |
|
| 155 |
[GO] |
2021―Nov―20 |
P1-34: Passive microwave radiometry as an early screening diagnostic of pneumonia due to coronavirus infection 2019 lung complications in Kyrgyzstan |
|
| 156 |
[GO] |
2021―Nov―20 |
P5-55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome? |
|
| 157 |
[GO] |
2021―Nov―20 |
P1-94: The challenges of patients that with home using long term oxygen therapy under coronavirus pandemic |
|
| 158 |
[GO] |
2021―Nov―20 |
P5-149: Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine |
|
| 159 |
[GO] |
2021―Nov―20 |
P13-1: Chest X-ray findings of coronavirus-19 disease in patients age 0 to 18 years old admitted at Chong Hua Hospital from March 2020 to February 2021 |
|
| 160 |
[GO] |
2021―Nov―20 |
O6-3: Bioinformatics analysis of high-throughput sequencing to identify key genes and signaling pathways in vero E6 cells infected by SARS-CoV-2 |
|
| 161 |
[GO] |
2021―Nov―20 |
P6-12: The cruel dual; SARS-CoV-2 and tuberculosis co-infection, the Sri Lankan experience |
|
| 162 |
[GO] |
2021―Nov―20 |
P5-24: Severity and clinical outcome of SARS-CoV-2 infected patients following COVID vaccination - An observational study in Bangladesh |
|
| 163 |
[GO] |
2021―Nov―20 |
P5-123: The clinical features and outcomes of discharged SARS-CoV-2 patients: A prospective cohort study |
|
| 164 |
[GO] |
2021―Nov―20 |
P2-40: Expression of the SARS-CoV-2 receptor ACE2 and proinflammatory cytokines induced by the periodontopathic bacterium
Fusobacterium nucleatum
in human respiratory epithelial cells |
|
| 165 |
[GO] |
2021―Nov―20 |
P5-41: Rapid and simultaneous identification of multiple mutations by the Novaplex
TM
SARS-CoV-2 variants assay kits |
|
| 166 |
[GO] |
2021―Nov―20 |
P10-24: Successful extubation in a phenobarbital overdose attempted suicide in a non-ideal set-up at the time of COVID 19 pandemic |
|
| 167 |
[GO] |
2021―Nov―20 |
P5-11: Vaccine-induced immune thrombotic thrombocytopenia (VITT) after
ChAdOx1 nCoV-19
vaccination |
|
| 168 |
[GO] |
2021―Nov―10 |
Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines |
Naoyuki Miyashita, Yasushi Nakamori, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Yoshihisa Ishiura, Shosaku Nomura |
| 169 |
[GO] |
2021―Sep―01 |
Mental health among healthcare workers during the
COVID
-19 pandemic |
Natasha Smallwood, Karen Willis |
| 170 |
[GO] |
2021―Aug―30 |
Air pollution and the pandemic: Long-term
PM
2.5
exposure and disease severity in
COVID
-19 patients |
Angelico Mendy, Xiao Wu, Jason L. Keller, Cecily S. Fassler, Senu Apewokin, Tesfaye B. Mersha, et al. (+2) Changchun Xie, Susan M. Pinney |
| 171 |
[GO] |
2021―Aug―24 |
Decline in respiratory and cardiac admissions during the
COVID
-19 pandemic: What is the role of common respiratory virus infections? |
Chloe I. Bloom, Sebastian L. Johnston |
| 172 |
[GO] |
2021―Aug―13 |
Risk of severe acute respiratory syndrome coronavirus 2 (
SARS-CoV
-2) transmission during bronchoscopy in the intensive care unit |
Biplab K. Saha, Praveen Chenna |
| 173 |
[GO] |
2021―Aug―08 |
Impact of
COVID
-19 pandemic restrictions on the cardio-respiratory health of New Zealanders |
Sarah M. Fairweather, Catherina L. Chang, Christopher J Mansell, Eskandarain Shafuddin, Robert J. Hancox |
| 174 |
[GO] |
2021―Jun―28 |
The 1918 influenza and
COVID
-19 pandemics: The effect of age on outcomes |
Paul T. King, Sarah L. Londrigan |
| 175 |
[GO] |
2021―May―27 |
Pathophysiology of infection with SARS-CoV
-2-
What is known and what remains
a
mystery |
Siddharth Sridhar, John Nicholls |
| 176 |
[GO] |
2021―Mar―08 |
Provision of essential bronchoscopy during
COVID
-19 pandemic |
Waheed Shah, Orla O'Carroll, Michael P. Keane, Cormac McCarthy |
| 177 |
[GO] |
2021―Mar―02 |
Letter from Canada: A pandemic that has humbled us? |
Stephan F. van Eeden |
| 178 |
[GO] |
2020―Dec―16 |
Delayed access to lung cancer screening and treatment during the
COVID
-19 pandemic: Are we headed for a lung cancer pandemic? |
Tracy L. Leong |
| 179 |
[GO] |
2020―Oct―14 |
Attenuating COVID-19 infection and inflammation: Lessons from asthma |
Philip G. Bardin, Sebastian L. Johnston |
| 180 |
[GO] |
2020―Sep―22 |
Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19 |
Priyanka Makkar, Stephen M Pastores |
| 181 |
[GO] |
2020―Sep―21 |
Pulmonary rehabilitation in
COVID
-19 pandemic era: The need for a revised approach |
Ajay Prashad Gautam, Ross Arena, Snehil Dixit, Audrey Borghi-Silva |
| 182 |
[GO] |
2020―Aug―18 |
Letter from Singapore: The clinical and research response to COVID-19 |
Sanjay H. Chotirmall, Lin-Fa Wang, John A. Abisheganaden |
| 183 |
[GO] |
2020―Jul―07 |
Universal public mask wear during
COVID
-19 pandemic: Rationale, design and acceptability |
Christopher Liu, Rawya Diab, Hasan Naveed, Victor Leung |
| 184 |
[GO] |
2020―Jun―17 |
Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with
SARS-CoV
-2 infection |
Tomas Raul Wiche Salinas, Boyang Zheng, Jean-Pierre Routy, Petronela Ancuta |
| 185 |
[GO] |
2020―May―21 |
The role of
SARS-CoV
-2 antibodies in
COVID
-19: Healing in most, harm at times |
Martyn A. French, Yuben Moodley |
| 186 |
[GO] |
2020―May―14 |
Safe performance of diagnostic bronchoscopy/
EBUS
during the
SARS-CoV
-2 pandemic |
Daniel P. Steinfort, Felix J.F. Herth, Louis B. Irving, Phan T. Nguyen |
| 187 |
[GO] |
2020―Apr―11 |
Summarizing societal guidelines regarding bronchoscopy during the COVID-19 pandemic |
Robert J. Lentz, Henri Colt |
